# Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome

> **NCT01263834** · PHASE2,PHASE3 · COMPLETED · sponsor: **Prince of Songkla University** · enrollment: 39 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Bevacizumab
- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT01263834
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2014-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01263834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01263834, "Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01263834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*